|
PF-34857 |
ALBURAAS 12.5 g /50 mL Solucion Inyectable |
2010-02-10 |
|
Shanghai Raas Blood Products Co Ltd |
República de China
|
Norvanda Healthcare, S A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38271 |
HEMORAAS 250 UI Polvo para Solución Inyectable |
2011-12-14 |
|
Shanghai Raas Blood Products Co Ltd |
República de China
|
Norvanda Healthcare, S A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33567 |
FIBRORAAS 0.5 g Polvo para uso parenteral |
2009-08-11 |
|
Shanghai Raas Blood Products Co Ltd |
República de China
|
Norvanda Healthcare, S A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33569 |
HEMORAAS 200 UI Polvo para uso parenteral |
2009-08-11 |
|
Shanghai Raas Blood Products Co Ltd |
República de China
|
Norvanda Healthcare, S A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33572 |
PROTHORAAS Polvo para uso Parenteral |
2009-08-11 |
|
Shanghai Raas Blood Products Co Ltd |
República de China
|
Norvanda Healthcare, S A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33573 |
INMUNOGLOBULINA INTRAVENOSA HUMANA Shangai 5 % Solución inyectable |
2014-08-11 |
|
Shanghai Raas Blood Products Co Ltd |
República de China
|
Norvanda Healthcare, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33574 |
ALBURAAS 10 g/50mL Solucion Inyectable |
2009-08-11 |
|
Shanghai Raas Blood Products Co Ltd |
República de China
|
Norvanda Healthcare, S A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56473 |
XELODA 500 mg Comprimidos recubiertos |
2024-03-18 |
|
F. Hoffmann-La Roche, S.A. |
República de China
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-35589 |
SHANVAC-B, Suspension Inyectable |
2010-07-08 |
|
Shantha Biotechnics Ltd. |
India
|
Conamep |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-53525 |
SHAN-5 Suspensión inyectable |
2021-11-14 |
|
Shantha Biotechnics Private Limited. |
India
|
Sanofi-Aventis De Guatemala |
J.I.Cohen, S.A. |
Servicio De Comercio Internacional |
Droguería Y Farmacia Lanquetin |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|